Suppr超能文献

预处理大鼠心脏中腺苷酸环化酶系统的激活

Activation of adenylate cyclase system in the preconditioned rat heart.

作者信息

Okruhlicová L, Ravingerová T, Pancza D, Tribulová N, Styk J, Stetka R

机构信息

Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.

出版信息

Physiol Res. 2000;49(2):251-9.

Abstract

Ischemic preconditioning (IP) protects the heart against subsequent prolonged ischemia. Whether the beta-adrenoceptor/adenylate cyclase pathway contributes to this cardioprotection is not yet fully known. Using enzyme catalytic cytochemistry we studied the adenylate cyclase activity and its distribution in the preconditioned rat heart. Adenylate cyclase activity was examined in Langendorff-perfused rat hearts subjected to the following conditions: control perfusion; 30 min regional ischemia; 5 min occlusion and 10 min reperfusion (IP); IP followed by ischemia. Ischemia-induced arrhythmias and the effect of ischemic preconditioning on the incidence of arrhythmias were analyzed. At the end of experiment the heart was shortly prefixed with glutaraldehyde. Tissue samples from the left ventricle were incubated in a medium containing the specific substrate AMP-PNP for adenylate cyclase and then routinely processed for electron microscopy. Adenylate cyclase activity was cytochemically demonstrated in the sarcolemma and the junctional sarcoplasmic reticulum (JSR) in control hearts, while it was absent after test ischemia. The highest activity of the precipitate was observed after ischemic preconditioning. In the preconditioned hearts followed by test ischemia, adenylate cyclase activity in the precipitate was preserved in sarcolemma and even more in JSR. Protective effect of ischemic preconditioning was manifested by the suppression of severe arrhythmias. These results indicate the involvement of the adenylate cyclase system in mechanisms underlying ischemic preconditioning.

摘要

缺血预处理(IP)可保护心脏免受随后的长时间缺血损伤。β-肾上腺素能受体/腺苷酸环化酶途径是否参与这种心脏保护作用尚不完全清楚。我们运用酶催化细胞化学方法研究了腺苷酸环化酶活性及其在预处理大鼠心脏中的分布。在Langendorff灌注的大鼠心脏中检测腺苷酸环化酶活性,实验设置如下条件:对照灌注;30分钟局部缺血;5分钟阻断和10分钟再灌注(IP);IP后再进行缺血。分析缺血诱导的心律失常以及缺血预处理对心律失常发生率的影响。实验结束时,心脏用戊二醛短暂固定。从左心室采集组织样本,置于含有腺苷酸环化酶特异性底物AMP-PNP的培养基中孵育,然后常规处理用于电子显微镜观察。在对照心脏中,腺苷酸环化酶活性在肌膜和连接肌浆网(JSR)中通过细胞化学方法得以证实,而在试验性缺血后则未检测到。缺血预处理后观察到沉淀物的活性最高。在经过预处理后再进行试验性缺血的心脏中,沉淀物中的腺苷酸环化酶活性在肌膜中得以保留,在JSR中保留得更多。缺血预处理的保护作用表现为严重心律失常受到抑制。这些结果表明腺苷酸环化酶系统参与了缺血预处理的潜在机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验